News Archive
Results from a clinical trial of eteplirsen, a drug designed to treat Duchenne muscular dystrophy, suggest that the therapy allows participants to walk farther than people treated with placebo and dramatically increases production of a protein vital to muscle growth and health.
Understanding evolution is one of the cornerstones of biology - evolution is, in fact, the sole explanation for life's diversity on our planet.
Celgene International Sà rl, a subsidiary of Celgene Corporation, (NASDAQ: CELG), announced final results from a phase II investigational study evaluating the combination of REVLIMID® (lenalidomide) and rituximab in 59 patients with relapsed or refractory chronic lymphocytic leukemia (CLL). These data were presented at the 53rd Annual Meeting of the American Society of Hematology in San Diego, CA.
In a first of its kind study, researchers from the University of North Carolina at Chapel Hill's Frank Porter Graham Child Development Institute evaluated the language use of black mothers in comparison with white mothers with the same education levels to measure the amount and complexity of the words they use with their infants and young children.
› Verified 6 days ago